O4‐02‐01: PHASE 2A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM‐0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS. (1st July 2019)

• Record Type: Journal Article
• Authors: Boxer, Adam L.; Moebius, Hans; Harris, Baruch; Boeve, Bradley F.; Borroni, Barbara; van Swieten, John C.; Grossman, Murray; Pasquier, Florence; Frisoni, Giovanni B.; Mummery, Catherine J.; Vandenberghe, Rik; Le Ber, Isabelle; Hannequin, Didier; McGinnis, Scott M.; Auriacombe, Sophie; Onofrj, Marco; Goodman, Ira J.; Riordan, Henry J.; Wisniewski, Gary; Hesterman, Jacob; Marek, Ken; Patzke, Holger; Koenig, Gerhard; Hilt, Dana
• Is Part Of: Alzheimer's & dementia. Volume 15:Supplement 7S(2019)Part 23
• Page Start: P1231
• Page End: P1232
• Publication Date: 2019-07-01
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1016/j.jalz.2019.06.4746
• Languages: English
• ISSNs: 1552-5260